Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020
- PMID: 32701941
- PMCID: PMC7377817
- DOI: 10.15585/mmwr.mm6929e2
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020
Abstract
Transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is ongoing in many communities throughout the United States. Although case-based and syndromic surveillance are critical for monitoring the pandemic, these systems rely on persons obtaining testing or reporting a COVID-19-like illness. Using serologic tests to detect the presence of SARS-CoV-2 antibodies is an adjunctive strategy that estimates the prevalence of past infection in a population. During April 28-May 3, 2020, coinciding with the end of a statewide shelter-in-place order, CDC and the Georgia Department of Public Health conducted a serologic survey in DeKalb and Fulton counties in metropolitan Atlanta to estimate SARS-CoV-2 seroprevalence in the population. A two-stage cluster sampling design was used to randomly select 30 census blocks in each county, with a target of seven participating households per census block. Weighted estimates were calculated to account for the probability of selection and adjusted for age group, sex, and race/ethnicity. A total of 394 households and 696 persons participated and had a serology result; 19 (2.7%) of 696 persons had SARS-CoV-2 antibodies detected. The estimated weighted seroprevalence across these two metropolitan Atlanta counties was 2.5% (95% confidence interval [CI] = 1.4-4.5). Non-Hispanic black participants more commonly had SARS-CoV-2 antibodies than did participants of other racial/ethnic groups (p<0.01). Among persons with SARS-CoV-2 antibodies, 13 (weighted % = 49.9; 95% CI = 24.4-75.5) reported a COVID-19-compatible illness,* six (weighted % = 28.2; 95% CI = 11.9-53.3) sought medical care for a COVID-19-compatible illness, and five (weighted % = 15.7; 95% CI = 5.1-39.4) had been tested for SARS-CoV-2 infection, demonstrating that many of these infections would not have been identified through case-based or syndromic surveillance. The relatively low seroprevalence estimate in this report indicates that most persons in the catchment area had not been infected with SARS-CoV-2 at the time of the survey. Continued preventive measures, including social distancing, consistent and correct use of face coverings, and hand hygiene, remain critical in controlling community spread of SARS-CoV-2.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Similar articles
-
Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.Public Health. 2021 Jan;190:132-134. doi: 10.1016/j.puhe.2020.11.014. Epub 2020 Nov 24. Public Health. 2021. PMID: 33453689 Free PMC article.
-
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):960-964. doi: 10.15585/mmwr.mm6929e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32701938 Free PMC article.
-
Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.Occup Environ Med. 2020 Dec;77(12):857-861. doi: 10.1136/oemed-2020-106676. Epub 2020 Aug 6. Occup Environ Med. 2020. PMID: 32764107
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
-
The Role of Antibody Testing for SARS-CoV-2: Is There One?J Clin Microbiol. 2020 Jul 23;58(8):e00797-20. doi: 10.1128/JCM.00797-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32350047 Free PMC article. Review.
Cited by
-
Estimation of SARS-CoV-2 Seroprevalence in Central North Carolina: Accounting for Outcome Misclassification in Complex Sample Designs.Epidemiology. 2023 Sep 1;34(5):721-731. doi: 10.1097/EDE.0000000000001625. Epub 2023 Jul 31. Epidemiology. 2023. PMID: 37527450 Free PMC article.
-
A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland.Microbiol Spectr. 2023 Aug 17;11(4):e0276522. doi: 10.1128/spectrum.02765-22. Epub 2023 Jun 8. Microbiol Spectr. 2023. PMID: 37289070 Free PMC article.
-
Estimating the Under-ascertainment of COVID-19 cases in Toronto, Ontario, March to May 2020.J Public Health Res. 2023 May 12;12(2):22799036231174133. doi: 10.1177/22799036231174133. eCollection 2023 Apr. J Public Health Res. 2023. PMID: 37197719 Free PMC article.
-
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic.PLoS One. 2023 Apr 19;18(4):e0269104. doi: 10.1371/journal.pone.0269104. eCollection 2023. PLoS One. 2023. PMID: 37075077 Free PMC article. Review.
-
One Health Investigation of SARS-CoV-2 in People and Animals on Multiple Mink Farms in Utah.Viruses. 2022 Dec 29;15(1):96. doi: 10.3390/v15010096. Viruses. 2022. PMID: 36680136 Free PMC article.
References
-
- Izrael D, Hoaglin DC, Battaglia MP. A SAS macro for balancing a weighted sample. Cary, NC: SAS Institute; 2000. https://support.sas.com/resources/papers/proceedings/proceedings/sugi25/...
-
- National Center for Health Statistics. Vintage 2018 bridged-race postcensal estimates. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2018. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#Vintag...
-
- Korn EL, Graubard BI. Confidence intervals for proportions with small expected number of positive counts estimated from survey data. Surv Methodol 1998;24:193–201. https://www150.statcan.gc.ca/n1/pub/12-001-x/1998002/article/4356-eng.pdf
-
- Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927;22:209–12. 10.1080/01621459.1927.10502953 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous

